Nasdaq Avro News Today

Aldebaran Capital LLC purchased a new position in shares of AVROBIO, Inc. (NASDAQ:AVRO – Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 470,130 shares of the company’s stock, valued at approximately $724,000. AVROBIO accounts for about 0.7% of […]

AVROBIO, Inc. (NASDAQ:AVRO – Get Free Report) was the recipient of a significant decrease in short interest in the month of December. As of December 15th, there was short interest totalling 711,700 shares, a decrease of 22.6% from the November 30th total of 919,000 shares. Currently, 1.9% of the shares of the company are short […]

Mizuho cut shares of AVROBIO (NASDAQ:AVRO – Free Report) from a buy rating to a neutral rating in a research report released on Monday, MarketBeat Ratings reports. Mizuho currently has $2.00 target price on the stock, down from their prior target price of $5.00. AVROBIO Price Performance NASDAQ AVRO opened at $1.33 on Monday. AVROBIO […]

AVROBIO (NASDAQ:AVRO – Get Free Report) and Clarus Therapeutics (OTCMKTS:CRXTQ – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, risk, earnings, institutional ownership, dividends, valuation and profitability. Institutional & Insider Ownership 60.0% of AVROBIO shares […]

AVROBIO, Inc. (NASDAQ:AVRO – Get Free Report) saw a large decline in short interest in the month of July. As of July 31st, there was short interest totalling 2,040,000 shares, a decline of 15.0% from the July 15th total of 2,400,000 shares. Approximately 5.5% of the company’s stock are sold short. Based on an average […]

AVROBIO, Inc. (NASDAQ:AVRO – Get Rating) was the target of a significant growth in short interest during the month of May. As of May 31st, there was short interest totalling 1,420,000 shares, a growth of 44.4% from the May 15th total of 983,300 shares. Based on an average trading volume of 2,170,000 shares, the days-to-cover […]

AVROBIO, Inc. (NASDAQ:AVRO – Get Rating) was the target of a significant decrease in short interest in April. As of April 30th, there was short interest totalling 975,800 shares, a decrease of 5.3% from the April 15th total of 1,030,000 shares. Based on an average trading volume of 1,270,000 shares, the short-interest ratio is currently […]

AVROBIO, Inc. (NASDAQ:AVRO – Get Rating) was the target of a large increase in short interest in the month of February. As of February 15th, there was short interest totalling 753,500 shares, an increase of 504.7% from the January 31st total of 124,600 shares. Approximately 2.0% of the company’s shares are short sold. Based on […]

Shares of AVROBIO, Inc. (NASDAQ:AVRO – Get Rating) have received an average recommendation of “Buy” from the nine brokerages that are covering the company, Marketbeat.com reports. Three analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average 12 month price objective among analysts that […]

Wall Street analysts expect that AVROBIO, Inc. (NASDAQ:AVRO – Get Rating) will post earnings per share of ($0.54) for the current fiscal quarter, Zacks Investment Research reports. Zero analysts have provided estimates for AVROBIO’s earnings, with the highest EPS estimate coming in at ($0.30) and the lowest estimate coming in at ($0.62). AVROBIO posted earnings […]